AVITA MEDICAL INC. - Announcements

0.75%

$1.34

Market Cap $121.4M

Healthcare Biotechnology

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

AVH	Trading Halt	PRICE SENSITIVE	16/05/11	9.91KB	Share
AVH	3rd Quarter Financial Results	PRICE SENSITIVE	29/04/11	153.1KB	Share
AVH	Quarterly Report	PRICE SENSITIVE	29/04/11	116.2KB	Share
AVH	Pilot Clinical Study presented at British Burns Association	PRICE SENSITIVE	27/04/11	134.26KB	Share
AVH	ReCell study on healing of Acute and Chronic Wounds	PRICE SENSITIVE	20/04/11	128.77KB	Share
AVH	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/11	191.05KB	Share
AVH	European ISO Quality Certification	PRICE SENSITIVE	02/02/11	151.27KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/11	109.26KB	Share
AVH	Placement and Unmarketable Parcel update	PRICE SENSITIVE	24/01/11	116.13KB	Share
AVH	China and Taiwan Update	PRICE SENSITIVE	30/11/10	602.11KB	Share
AVH	CEO Contract Extension	PRICE SENSITIVE	22/11/10	569.48KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	26.38KB	Share
AVH	US Military Contract for ReCell	PRICE SENSITIVE	15/09/10	124.34KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	31/08/10	79.59KB	Share
AVH	FY 2010 Sales up 22% - June Quarterly Cash Flow	PRICE SENSITIVE	28/07/10	119.06KB	Share
AVH	USA ReCell Spray-on-Skin Enrolment Commences	PRICE SENSITIVE	10/06/10	219.94KB	Share
AVH	Secures USD$6m Convertible Note Facility	PRICE SENSITIVE	07/06/10	90.27KB	Share
AVH +HCG	China and Taiwan Product Distribution Update	PRICE SENSITIVE	31/05/10	123.32KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/10	89.84KB	Share
AVH	ReCell Regulatory approval in Taiwan	PRICE SENSITIVE	31/03/10	31.23KB	Share
AVH	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/10	245.45KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	101.18KB	Share
AVH	Receives additional Grant from US Armed Forces	PRICE SENSITIVE	28/01/10	98.55KB	Share
AVH	Completes ISO Quality Certification Audit	PRICE SENSITIVE	21/01/10	122.92KB	Share
AVH	Response to ASX Price Query	PRICE SENSITIVE	14/12/09	53.19KB	Share
AVH	FDA approves ReCell USA Clinical Trial	PRICE SENSITIVE	08/12/09	50.19KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	39.6KB	Share
AVH	Japanese Patent Granted	PRICE SENSITIVE	06/10/09	29.5KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	31/08/09	68.4KB	Share
AVH	ReCell Cleared for Sales in China	PRICE SENSITIVE	17/08/09	32.17KB	Share
AVH	USA ReCell AFIRM Clinical Study to Commence	PRICE SENSITIVE	13/08/09	35.97KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/09	39.58KB	Share
AVH	Secures $5m Funding Facility	PRICE SENSITIVE	20/07/09	32.46KB	Share
AVH	Awarded $2m to accelerate approval in US market	PRICE SENSITIVE	27/05/09	37.9KB	Share
AVH	Quarterly Cash Flow	PRICE SENSITIVE	01/05/09	29.2KB	Share
AVH	Respiratory Sales up 72%	PRICE SENSITIVE	02/04/09	35.49KB	Share
AVH	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/09	320.82KB	Share
AVH	Avita Streamlines Operations and Reduces costs	PRICE SENSITIVE	11/02/09	34.74KB	Share
AVH	Quarterly Cash Flow - Cash receipts up over 600%	PRICE SENSITIVE	30/01/09	65.63KB	Share
AVH	Avita Medical Receives ISO Certification	PRICE SENSITIVE	14/01/09	28.78KB	Share
AVH	French Ministry of Health in 200 Patient ReCell Study	PRICE SENSITIVE	16/12/08	33.66KB	Share

AVHTrading Halt
16/05/11	PRICE SENSITIVE	9.91KB	Share
AVH3rd Quarter Financial Results
29/04/11	PRICE SENSITIVE	153.1KB	Share
AVHQuarterly Report
29/04/11	PRICE SENSITIVE	116.2KB	Share
AVHPilot Clinical Study presented at British Burns Association
27/04/11	PRICE SENSITIVE	134.26KB	Share
AVHReCell study on healing of Acute and Chronic Wounds
20/04/11	PRICE SENSITIVE	128.77KB	Share
AVHHalf Yearly Report and Accounts
25/02/11	PRICE SENSITIVE	191.05KB	Share
AVHEuropean ISO Quality Certification
02/02/11	PRICE SENSITIVE	151.27KB	Share
AVHAppendix 4C - quarterly
31/01/11	PRICE SENSITIVE	109.26KB	Share
AVHPlacement and Unmarketable Parcel update
24/01/11	PRICE SENSITIVE	116.13KB	Share
AVHChina and Taiwan Update
30/11/10	PRICE SENSITIVE	602.11KB	Share
AVHCEO Contract Extension
22/11/10	PRICE SENSITIVE	569.48KB	Share
AVHAppendix 4C - quarterly
29/10/10	PRICE SENSITIVE	26.38KB	Share
AVHUS Military Contract for ReCell
15/09/10	PRICE SENSITIVE	124.34KB	Share
AVHPreliminary Final Report
31/08/10	PRICE SENSITIVE	79.59KB	Share
AVHFY 2010 Sales up 22% - June Quarterly Cash Flow
28/07/10	PRICE SENSITIVE	119.06KB	Share
AVHUSA ReCell Spray-on-Skin Enrolment Commences
10/06/10	PRICE SENSITIVE	219.94KB	Share
AVHSecures USD$6m Convertible Note Facility
07/06/10	PRICE SENSITIVE	90.27KB	Share
AVH +HCGChina and Taiwan Product Distribution Update
31/05/10	PRICE SENSITIVE	123.32KB	Share
AVHAppendix 4C - quarterly
29/04/10	PRICE SENSITIVE	89.84KB	Share
AVHReCell Regulatory approval in Taiwan
31/03/10	PRICE SENSITIVE	31.23KB	Share
AVHHalf Yearly Report and Accounts
26/02/10	PRICE SENSITIVE	245.45KB	Share
AVHAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	101.18KB	Share
AVHReceives additional Grant from US Armed Forces
28/01/10	PRICE SENSITIVE	98.55KB	Share
AVHCompletes ISO Quality Certification Audit
21/01/10	PRICE SENSITIVE	122.92KB	Share
AVHResponse to ASX Price Query
14/12/09	PRICE SENSITIVE	53.19KB	Share
AVHFDA approves ReCell USA Clinical Trial
08/12/09	PRICE SENSITIVE	50.19KB	Share
AVHAppendix 4C - quarterly
30/10/09	PRICE SENSITIVE	39.6KB	Share
AVHJapanese Patent Granted
06/10/09	PRICE SENSITIVE	29.5KB	Share
AVHPreliminary Final Report
31/08/09	PRICE SENSITIVE	68.4KB	Share
AVHReCell Cleared for Sales in China
17/08/09	PRICE SENSITIVE	32.17KB	Share
AVHUSA ReCell AFIRM Clinical Study to Commence
13/08/09	PRICE SENSITIVE	35.97KB	Share
AVHAppendix 4C - quarterly
31/07/09	PRICE SENSITIVE	39.58KB	Share
AVHSecures $5m Funding Facility
20/07/09	PRICE SENSITIVE	32.46KB	Share
AVHAwarded $2m to accelerate approval in US market
27/05/09	PRICE SENSITIVE	37.9KB	Share
AVHQuarterly Cash Flow
01/05/09	PRICE SENSITIVE	29.2KB	Share
AVHRespiratory Sales up 72%
02/04/09	PRICE SENSITIVE	35.49KB	Share
AVHHalf Yearly Report and Accounts
27/02/09	PRICE SENSITIVE	320.82KB	Share
AVHAvita Streamlines Operations and Reduces costs
11/02/09	PRICE SENSITIVE	34.74KB	Share
AVHQuarterly Cash Flow - Cash receipts up over 600%
30/01/09	PRICE SENSITIVE	65.63KB	Share
AVHAvita Medical Receives ISO Certification
14/01/09	PRICE SENSITIVE	28.78KB	Share
AVHFrench Ministry of Health in 200 Patient ReCell Study
16/12/08	PRICE SENSITIVE	33.66KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.34		Change 0.010(0.75%)		Mkt cap ! $121.4M

Open	High	Low	Value	Volume
$1.34	$1.37	$1.34	$885.1K	655.8K

Buyers (Bids)

No.	Vol.	Price($)
11	26617	$1.34

Sellers (Offers)

Price($)	Vol.	No.
$1.35	150	1

View Market Depth

No.	Vol.	Price($)
8	22348	1.340
4	7743	1.335
8	38687	1.330
6	22530	1.325
4	24270	1.320

Price($)	Vol.	No.
1.345	150	1
1.350	1551	1
1.360	5957	1
1.380	8058	2
1.390	978	1

Last trade - 16.10pm 05/09/2025 (20 minute delay)

AVH (ASX) Chart

AVITA MEDICAL INC. - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories